PIMREG and cancer: The addition of CATs to FASNKO HAP1 cells was followed by an immediate and time-dependent reduction in normalized CI values (Fig. 3A), which quickly reached background levels, consistent with a complete cytolysis of the target FASNKO HAP1 cancer cells.